Torno Capital, LLC Exelixis, Inc. Call Options Transaction History

Torno Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $1.68 Million - $1.96 Million	-82,800 Reduced 64.69%	45,200 $1.02 Billion
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $841,089 - $997,881	41,700 Added 48.32%	128,000 $3.04 Billion
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $1.66 Million - $2.08 Million	86,300 New	86,300 $2.07 Billion

498

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Torno Capital, LLC with notifications on news.